Stay updated on Cabozantinib in Advanced Solid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Solid Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a software/template update to the ClinicalTrials.gov page. This change does not alter any study details, eligibility criteria, or reported results.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the prior Revision: v3.6.3. This appears to be a minor metadata/version update reflecting an updated page build.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.2. This indicates a minor version update to the page rendering rather than changes to the study information.SummaryDifference0.1%

- Check54 days agoChange DetectedThe site revision was updated from v3.6.0 to v3.6.2, indicating a deployment of updates to the ClinicalTrials.gov interface or backend. The change does not modify the study content or data displayed on the page.SummaryDifference0.1%

- Check68 days agoChange DetectedNew recruitment status indicates that the study is no longer looking for participants, and the page gains new help/navigation links such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment heading formatting was adjusted, and a site revision note Revision: v3.6.0 was added.SummaryDifference0.5%

- Check75 days agoChange DetectedRevision: v3.5.5 appears on the page, replacing the previous Revision: v3.5.4. This indicates a software revision update underlying the page.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Advanced Solid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.